Researchers from the University of Kentucky found that most of the cannabidiol-gummies they tested had inaccurate labeling.
The CBD industry in the USA has been plagued by labeling problems for many years. This situation does not seem to improve.
In this new study, the cannabinoid content of 56 selected cannabidiol gummy products available online from national brands were analyzed using liquid chromatography-tandem mass spectrometry.
70 % of all gummies were CBD-rich, but the concentrations varied by at least 10% from what was stated on their packaging. Three-quarters of products were delta-9 and other contained delta-8. It was especially problematic when the THC content in any amount is not mentioned on labels. Although the THC was low, it may be sufficient to result in a positive test.
Researchers concluded that:
“This study further confirms that CBD products do not have reliable CBD concentrations-both relative to the dose listed on the label and among individual gummies within the same bottle … The results of this study support the growing body of literature suggesting the necessity of CBD product regulation to ensure customer health and safety.”
This study was conducted to determine the effectiveness of a particular treatment. has been published Cannabis and Cannabidiol Research.
The USA’s FDA has been repeatedly pushed to get on top of the situation by implementing and enforcing regulatory guidelines. The FDA said in 2023 that it needed a different regulatory path for CBD, and was not in the position to do so. After two years, not much has been changed.
Jonathan Miller, US Hemp Roundtable’s General Counsel testified before the U.S. House Oversight Committee in April of this year regarding FDA’s failure to regulate hemp products and CBD.
The FDA is needed to prevent this from happening. “As an industry we strongly oppose these products being sold to children. We are also against their marketing to them.
Miller argued that there were several tools under the current law which the FDA can use right away, but they have chosen to not do so.
The USA isn’t the only country where mislabelling of cannabidiol products has been rife – it has also been a significant issue in the UK.